The state-backed Food and Environment Reseach Agency remains a shareholder in Forsite having taken a stake when the portfolio company was spun out from the UK's agriculature department in 2007.
Abingdon Health, a portfolio company of UK-listed university technology commercialization and investment group Imperial Innovations, has made an investment and acquired a controlling 80% interest in Forsite Diagnostics, a local medical contract developer. The state-backed Food and Environment Reseach Agency remains a shareholder in Forsite having taken a stake when the portfolio company was spun out from…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
